Global coronary artery disease treatment devices market expected to reach over $8 billion by 2019, says Technavio

Renewable energy

 

This market study segments the global coronary artery disease treatment devices market by product type (coronary stents, PTCA balloon catheters, and coronary guidewires) and by geography (Americas, EMEA, and APAC). Key leading vendors analyzed in this market research report are Abbott Vascular, Boston Scientific, Medtronic, and Terumo.

Technavio has released its new market research report, global coronary artery disease treatment devices market, which is expected to grow at a CAGR of around 6% between 2015 and 2019. The global market for coronary artery disease treatment devices is positively influenced by factors like the high incidence of cardio vascular diseases (CVDs) among the populace. The coronary artery disease treatment devices include coronary stents, PTCA balloon catheters, and coronary guidewires. The Americas dominate the global market, accounting for around 44% of the overall market revenue. The high incidence of cardiac disorders among Americans is a significant factor that propels growth in this region during the forecast period.

“The market is observing increased utilization of stents by doctors in the coronary artery disease treatment. This has encouraged the manufacturers to come up with various kinds of stents including bioabsorbable scaffolds, biodegradable polymers, and bifurcation stents. These stents eliminate the negative issues of durable polymer stents. Also, the bioabsorbable drug-eluting stent has better clinical advantages than drug-eluting stents,” says Imran Mushtaq, Lead Analyst, Healthcare & Sciences, Technavio Research.

Percutaneous transluminal coronary angioplasty (PTCA) is a minimally invasive procedure used to remove the blockage of coronary arteries. The procedure includes the usage of stents, balloon catheters, and guidewires to remove the plaques and widen the damaged coronary artery. High demand for minimally invasive procedures among patients and surgeons has encouraged various technological advancements in PTCA balloon catheters and coronary stents. Now-a-days, the cardiac surgeons are integrating stenting with PTCA balloon catheter to reduce re-blockage of the artery.

The leading vendors in the global coronary artery disease treatment devices market are Abbott Vascular, Medtronic, Boston Scientific, and Terumo. This market is highly organized and competitive due to the presence of many large, medium, and small vendors. The multinational vendors occupy a large part of the global market and continually compete with each other to gain majority shares in the market. The competitive environment in this market is expected to intensify during the forecast period owing to advances in technology, product extensions, and increased M&A.

A more detailed analysis is available in the Technavio report, Global Coronary Artery Disease Treatment Devices Market 2015-2019.

We can customize this reports by other regions and specific segments upon request.

Other Related Reports: